Krystal Biotech, Inc. is a biotechnology company that develops and delivers transformative medicines for people with serious and life-threatening genetic diseases.
Regional Gene Therapy Consultant will be a self-starter, responsible for the successful launch of Vyjuvek for the treatment of patients with dystrophic epidermolysis bullosa (DEB) within their given territory. They will promote the product to pediatric dermatologists and other key stakeholders, and build consultative sales relationships with customers and prospects.
Krystal Biotech, Inc. is a biotechnology company that develops and delivers transformative medicines for people with serious and life-threatening genetic diseases.
Krystal Biotech, Inc.